Ken Markus - Innovid Corp Chief Officer
| CTVDelisted Stock | USD 3.14 0.00 0.00% |
Insider
Ken Markus is Chief Officer of Innovid Corp
| Age | 49 |
| Phone | 212 966 7555 |
| Web | https://www.innovid.com |
Ken Markus Latest Insider Activity
Tracking and analyzing the buying and selling activities of Ken Markus against Innovid Corp stock is an integral part of due diligence when investing in Innovid Corp. Ken Markus insider activity provides valuable insight into whether Innovid Corp is net buyers or sellers over its current business cycle. Note, Innovid Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Innovid Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Ken Markus over three months ago Disposition of 2191 shares by Ken Markus of Innovid Corp at 1.6968 subject to Rule 16b-3 |
Innovid Corp Management Efficiency
The company has Return on Asset of (0.0257) % which means that on every $100 spent on assets, it lost $0.0257. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0702) %, meaning that it generated no profit with money invested by stockholders. Innovid Corp's management efficiency ratios could be used to measure how well Innovid Corp manages its routine affairs as well as how well it operates its assets and liabilities.Innovid Corp has 21.83 M in debt with debt to equity (D/E) ratio of 0.09, which may show that the company is not taking advantage of profits from borrowing. Innovid Corp has a current ratio of 2.64, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Innovid to invest in growth at high rates of return.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Amanda Hamilton | ADC Therapeutics SA | N/A | |
| Kimberly Pope | ADC Therapeutics SA | 58 | |
| Richard Onyett | ADC Therapeutics SA | 73 | |
| Lisa Skelton | ADC Therapeutics SA | 53 | |
| MS MBA | ADC Therapeutics SA | 52 | |
| Ashish Chand | Belden Inc | 50 | |
| Dr DPHIL | ADC Therapeutics SA | 65 | |
| Gregory McCray | Belden Inc | 57 | |
| Colonel Atcheson | Comtech Telecommunications Corp | N/A | |
| Leah Tate | Belden Inc | 48 | |
| Maria Hedden | Comtech Telecommunications Corp | 54 | |
| Stephen Evansfreke | ADC Therapeutics SA | 68 | |
| Lajuana Johnson | Comtech Telecommunications Corp | N/A | |
| Jennie Reilly | Comtech Telecommunications Corp | N/A | |
| Kevin Maczka | Belden Inc | N/A | |
| Scott DAngelo | CTS Corporation | 54 | |
| Michael Mulkerrin | ADC Therapeutics SA | 69 | |
| Susan Romanus | ADC Therapeutics SA | 59 | |
| Jacques Theurillat | ADC Therapeutics SA | 62 | |
| Thomas White | CTS Corporation | 38 | |
| Ronan Kelly | ADTRAN Inc | N/A | |
Management Performance
| Return On Equity | -0.0702 | |||
| Return On Asset | -0.0257 |
Innovid Corp Leadership Team
Elected by the shareholders, the Innovid Corp's board of directors comprises two types of representatives: Innovid Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Innovid. The board's role is to monitor Innovid Corp's management team and ensure that shareholders' interests are well served. Innovid Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Innovid Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tanya AndreevKaspin, Executive Officer | ||
| Tim Braz, VP Sales | ||
| Stephanie Geno, Chief Officer | ||
| Stephen Cook, General Counsel | ||
| Ken Markus, Chief Officer | ||
| John Williams, Head Relations | ||
| Pr Netter, CEO CoFounder | ||
| Michal Livny, Executive Resources | ||
| Alex Rowe, Senior Sales | ||
| Anthony Callini, Chief Officer | ||
| Dani Cushion, Chief Officer | ||
| David Helmreich, Chief Officer | ||
| Jeff Austin, Senior Operations | ||
| Kenneth Markus, Chief Officer | ||
| Liel Golan, Executive Operations | ||
| Yuval Pemper, Chief Officer | ||
| Sarah Ripmaster, Senior Accounts | ||
| Tal Chalozin, CoFounder CTO | ||
| Arik Shahar, VP Measurement | ||
| Guy Kuperman, Chief Officer |
Innovid Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Innovid Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0702 | |||
| Return On Asset | -0.0257 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | (0.04) % | |||
| Current Valuation | 450.54 M | |||
| Shares Outstanding | 150.92 M | |||
| Shares Owned By Insiders | 7.27 % | |||
| Shares Owned By Institutions | 55.65 % | |||
| Number Of Shares Shorted | 3.46 M | |||
| Price To Earning | 23.87 X |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Innovid Stock
If you are still planning to invest in Innovid Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Innovid Corp's history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |